Skip to main content
. 2018 May 25;78(5):589–598. doi: 10.1097/QAI.0000000000001723

FIGURE 2.

FIGURE 2.

Proportion of participants with HIV-1 RNA <40 copies per milliliterover time, Food and Drug Administration snapshot approach. Raltegravir (RAL) 1200 mg QD and 400 mg BID were given with TDF/FTC.